Clinical Trials Browser

Phase 2 × Not yet recruiting × Bile Duct Neoplasms × Clear all

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06274879 2025-01-09

Ablatio

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms

NCT06730581 2024-12-12

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

Phase 2 Not yet recruiting

GastrointestinalGynecologic

Bile Duct Neoplasms, Ovarian Neoplasms, Stomach Neoplasms